SAN DIEGO, August 09, 2012 /PRNewswire/ — Medical Marijuana Inc (OTC: MJNA) a leading hemp industry innovator, is pleased to announce a comprehensive update on it’s industrial hemp crop related activities. Company representatives of Medical Marijuana Inc. have been traveling the globe over the past year investigating several proprietary sources of industrial hemp production. Industrial hemp is the key component plant for the Company’s new whole-plant extract, CBD-infused health and wellness products.
Industrial Hemp Planted on Over 1200 Hectares (nearly 3,000 acres)
Internationally in hemp-legal countries, Medical Marijuana’s business affiliates have to date, planted over 1200 hectares (1 hectare equals 2.47 acres) of industrial hemp crops. Expected to mature early this fall, the crops are off to a great start as a wet spring and early summer have provided the crops an optimal growing platform. The crops are expected to grow to a height of 14 feet and will be used for a variety of purposes besides the hemp based extracts and compounds. It has been estimated that there are over 50,000 industrial uses for hemp.
Additional Hemp Production Being Investigated – 4 Production Facilities in Play
Medical Marijuana Inc. is currently investing in hemp production companies as well as contracting with expert agricultural facilities in order to produce industrial hemp using the Company’s specialized genetic cultivars. Presently our team of experts are analyzing various countries and climate zones for optimal production capabilities. Certain cultivars grow better in certain climates and micro-climate regions. The Company is seeking to optimize production from our high-CBD varieties that have been developed over the last several years.
The Company now has four Agricultural Production Facilities where their unique extraction technology produces high concentration whole plant hemp-based CBD Essential Oil. This CBD Essential Oil is being sold in bulk quantity to agricultural production companies, as evidenced by the $7.5 million contract recently reported, or used for the Company’s proprietary product portfolio, specifically the Dixie X product line. Dixie X products will be available on over-the-counter markets and on our retail sales sites on September 5th 2012.
The following pictures illustrate the Company’s Industrial Hemp Crop at various stages of development, MJNA will continue to update its shareholders on the status of the individual production facilities:
“It is very fulfilling to see our teams hard work and dedication realized with the production of our oils and products. We are very pleased with where the company is currently positioned, in terms of our facilities production capabilities and the retail sales opportunities for our products, specifically our high grade CBD oils and extracts. We appreciate our continued support from our shareholders and look forward to updating them accordingly.” Said Michael Llamas, President of Medical Marijuana Inc.”
About Medical Marijuana, Inc
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value.
Medical Marijuana Inc. does not grow, sell or distribute any substances that violate United States Law or the controlled substance act.
For more information, please visit the company’s website at: www.MedicalMarijuanaInc.com
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
Investor Relations Contact:
Stuart T. Smith
SOURCE Medical Marijuana Inc.